Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Hyun Sung MD, PhD

Hyun Hwan Sung MD, PhD

Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas

Disclosures

Dr. Sung has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Maintenance Pembrolizumab After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
  2. Molecular Lymph Node Staging for Bladder Cancer Patients Undergoing Radical Cystectomy

Recently Updated